The SPHS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SPHS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The SPHS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View SPHS Detailed Price Forecast - CNN Money||View SPHS Detailed Summary - Google Finance|
|View SPHS Detailed Summary - Yahoo! Finance||View SPHS Stock Research & Analysis - Zacks.com|
|View SPHS Trends & Analysis - Trade-Ideas||View SPHS Major Holders - Barrons|
|View SPHS Call Transcripts - NASDAQ||View SPHS Breaking News & Analysis - Seeking Alpha|
|View SPHS Annual Report - CompanySpotlight.com||View SPHS OTC Short Report - OTCShortReport.com|
|View SPHS Fundamentals - TradeKing||View SPHS SEC Filings - Bar Chart|
|View Historical Prices for SPHS - The WSJ||View Performance/Total Return for SPHS - Morningstar|
|View the Analyst Estimates for SPHS - MarketWatch||View the Earnings History for SPHS - CNBC|
|View the SPHS Earnings - StockMarketWatch||View SPHS Buy or Sell Recommendations - MacroAxis|
|View the SPHS Bullish Patterns - American Bulls||View SPHS Short Pain Metrics - ShortPainBot.com|
|View SPHS Stock Mentions - StockTwits||View SPHS Stock Mentions - PennyStockTweets|
|View SPHS Stock Mentions - Twitter||View SPHS Investment Forum News - Investor Hub|
|View SPHS Stock Mentions - Yahoo! Message Board||View SPHS Stock Mentions - Seeking Alpha|
|View Insider Transactions for SPHS - SECform4.com||View Insider Transactions for SPHS - Insider Cow|
|View SPHS Major Holdings Summary - CNBC||View Insider Disclosure for SPHS - OTC Markets|
|View Insider Transactions for SPHS - Yahoo! Finance||View Institutional Holdings for SPHS - NASDAQ|
|View SPHS Stock Insight & Charts - FinViz.com||View SPHS Investment Charts - StockCharts.com|
|View SPHS Stock Overview & Charts - BarChart||View SPHS User Generated Charts - Trading View|
Sophiris Bio Provides Updates on Phase 2b Localized Prostate Cancer Trial
Posted on Monday December 17, 2018
SAN DIEGO and VANCOUVER, British Columbia, Dec. 17, 2018 /PRNewswire/ -- Sophiris Bio Inc. (SPHS) (the "Company" or "Sophiris"), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class, pore-forming protein, in late-stage clinical trials for the treatment of patients with urological diseases, today provides an update from its Phase 2b study of topsalysin for localized prostate cancer, including top-line safety and biopsy results from the patients who received a second administration of study drug, which appeared to be safe and generally well-tolerated. Additional benefit was not observed on targeted biopsy six months after re-treatment with a second administration of topsalysin. As previously stated, a total of 27% of patients (10/37) demonstrated a clinical response six months following a single administration of topsalysin.
Does Sophiris Bio Inc (FRA:BFF1) Have A Volatile Share Price?
Posted on Thursday December 06, 2018
If you own shares in Sophiris Bio Inc (FRA:BFF1) then it's worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure Read More...
SPHS: Data from Second Administration of Topsalysin in Phase 2b Trial Anticipated Before End of 2018…
Posted on Tuesday November 20, 2018
By David Bautz, PhD NASDAQ:SPHS READ THE FULL SPHS RESEARCH REPORT Business Update Interim Safety and Efficacy Data for Phase 2b Trial of Topsalysin in Localized Prostate Cancer Earlier in 2018, Sophiris ...
Report: Exploring Fundamental Drivers Behind HC2, Pangaea Logistics Solutions, Sophiris Bio, Acacia Research, JAKKS Pacific, and LeMaitre Vascular — New Horizons, Emerging Trends, and Upcoming Developments
Posted on Friday November 16, 2018
NEW YORK, Nov. 16, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.